FAP CAR T-Cells Update 10/2017
CLINICAL TRIAL FUND ANNOUNCEMENT (OCTOBER, 2017)
Fund Update from Dr. Steven Albelda: Dr. Albelda and the team at Penn Medicine’s Abramson Cancer Center continue to seek funding for the FAP-CAR clinical trial. Most recently, Dr. Albelda submitted a large grant to the National Cancer Institute in September. In addition, we were also invited to submit a grant to “Stand Up to Cancer” (one of 5 groups selected). In the meanwhile, Dr. Toru Kimura is performing additional experiments in our mouse models to prove the efficacy of the CAR attacking human FAP.
We use cookies to enhance your experience with this website. By continuing to interact with this website, you agree to our use of cookies. To learn more, click here.